Formerly a healthcare reporter, Christina now advises early- and late-stage healthcare companies on go-to-market strategy, storytelling, and fundraising, and shares her insights via Second Opinion.
A conversation with founder and cardiologist Dr. Jeff Wessler and his assessment on what separates longevity from prevention & public health
One tiny fund I hadn’t heard of absolutely crushed it
More perspectives from experienced operators on the great build vs. buy question for fundamental technology used by digital health cos
This is a hot topic and I’ve heard plenty of arguments with both sides. Here’s my POV.
Lets compare the s-1s of two interesting digital health companies are going public in 2025
What are the hidden trade offs of fund size. When should founders be able to take money off the table?
Employers tell me that preventative health is harder than ever
Omada got its start in 2011.
And no, ChatGPT is not the answer
The age old question revisited, but with a 2025 spin
Paid marketing is still useful - but competitive ad markets require more creativity
How healthcare founders should take lessons from teams navigating unpredictable events
What is keeping employers up at night going into 2025? A conversation with Chris Michalak
My takeaway from today’s news that the company is filing for bankruptcy
Between Function Health, Lifeforce and Superpower, this space is on fire
A few thoughts...
And what are the pros and cons?
I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health
Some digital health companies are getting more targeted with their approach
And it’s rapidly evolving in real time!
Let’s get real about the alliance between U.S. health care and employment
Plus, some thoughts about Transcarent buying Accolade!
Because so many of you asked for it!
Things have gotten a little better in digital health VC land, but it’s still challenging out there!
How I’ve been thinking about recent events
